MannKind Corp
MNKD
#5698
Rank
NZ$2.39 B
Marketcap
NZ$7.45
Share price
7.44%
Change (1 day)
-22.65%
Change (1 year)

Market capitalization of MannKind Corp (MNKD)

Market cap: NZ$2.39 Billion

As of November 2026 MannKind Corp has a market cap of NZ$2.39 Billion. This makes MannKind Corp the world's 5698th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MannKind Corp from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.39 B-21.94%
2025NZ$3.06 B-7.95%
2024NZ$3.33 B114.93%
2023NZ$1.55 B-28.98%
2022NZ$2.18 B35.9%
2021NZ$1.60 B57.24%
2020NZ$1.02 B152.01%
2019NZ$0.40 B37.25%
2018NZ$0.29 B-23.89%
2017NZ$0.38 B-11.69%
2016NZ$0.43 B-51.58%
2015NZ$0.90 B-66.4%
2014NZ$2.70 B15.62%
2013NZ$2.33 B191.02%
2012NZ$0.80 B90.91%
2011NZ$0.42 B-68.49%
2010NZ$1.33 B-2.06%
2009NZ$1.36 B126.09%
2008NZ$0.60 B-42.77%
2007NZ$1.05 B-38.65%
2006NZ$1.71 B221.79%
2005NZ$0.53 B-25.36%
2004NZ$0.71 B

End of Day market cap according to different sources

On Nov 8th, 2026 the market cap of MannKind Corp was reported to be:

NZ$2.22 Billion
by Nasdaq info icon info icon
NZ$2.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$296.24 B 12,262.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$324.42 B 13,438.50%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$2.236 T 93,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$652.08 B 27,112.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$20.86 B 770.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$2.29 B-4.17%๐Ÿ‡บ๐Ÿ‡ธ USA